Study Finds Competitors’ Aspergillus Assays Return False-Positive Results
Medicinal Genomics
OCTOBER 4, 2022
Our latest pre-print study , provides evidence that two competitors’ Aspergillus qPCR assays inappropriately amplify Aspergillus tamarii, causing false-positive results that could potentially lead to millions of dollars in crop loss. When we reviewed our competitors’ PTM reports, we saw that A.
97 
Let's personalize your content